Back to Search
Start Over
US clinical trials begin for twice-yearly HIV prevention injection
- Source :
- PharmaBiz. June 6, 2024
- Publication Year :
- 2024
-
Abstract
- Two clinical trials have launched to examine a novel long-acting form of HIV pre-exposure prophylaxis (PrEP) in cisgender women and people who inject drugs. The mid-stage studies will assess the [...]
- Subjects :
- United States. National Institutes of Health
United States. National Institute of Allergy and Infectious Diseases
Gilead Sciences Inc. -- Product development
Biological products industry -- Product development
HIV (Viruses) -- Prevention
Highly active antiretroviral therapy
Sexually transmitted diseases -- Prevention
Clinical trials
Emtricitabine -- Product development
Pharmaceuticals and cosmetics industries
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.796552020